Ceremorphic, a fabless silicon and system development company, announced the formation of a new life sciences division called “Ceremorphic Life Sciences,” which has been established to transform the entire drug discovery and development process. The new division will have access to Ceremorphic’s own proprietary analog and AI technology platform...
Insmed Incorporated, a global biopharmaceutical company, announced a collaboration with Google Cloud to transform the drug discovery, development, and commercialization landscape of the life sciences industry through the use of generative AI. This alliance will harness the power of Google Cloud's cutting-edge AI technology and Insmed's expertise in serious...
First out-of-the-box, low-code SaaS platform designed together by scientists and technologists to shorten drug discovery funnel, reduce costs of drug therapy R&D
Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announced the launch of Dotmatics Luma™, a revolutionary new scientific data platform that helps scientists and...
LumiraDx Limited, a next-generation point of care diagnostics company, is pleased to announce a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub, set to go live in November.
The official charity of Everton Football Club will run this...
ZoomRx, a pioneering force in technological solutions for the life sciences sector, announced the launch of their latest innovation: the Ferma Engine. This groundbreaking platform serves as both an incubator and innovation hub for pharma and biotech professionals to build their own generative AI solutions.
At its core, the Ferma...
ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced its strategic collaboration with Optellum Ltd (Oxford, UK), a global leader in AI clinical decision support for early lung cancer diagnosis and precision treatment planning. Through this partnership, the Optellum Virtual Nodule Clinic solution will be seamlessly integrated...
AI has become an increasingly valuable tool in the field of biotechnology. Across various sectors like pharmaceuticals, healthcare, animal husbandry, agriculture, and AI and machine learning (ML) technologies are reshaping processes to achieve more precise and efficient outcomes. The integration of AI in biotechnology holds immense potential for driving...
OptimizeRx Corp, the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, announced it has signed an agreement to acquire Scottsdale, Arizona-based Healthy Offers, Inc., dba Medicx Health ("Medicx”), a leading healthcare consumer-focused omnichannel marketing and analytics company. The transaction...
Former BMS, Pfizer leader to help AI-driven company accelerate its development of novel medicines discovered via its proprietary RNA foundation model
Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced the addition of Manjunath “Manju” Ramarao, Ph.D., as Chief Scientific...
Perimeter Medical Imaging AI, Inc. – a commercial-stage medical technology company – announced that patient randomization is underway at Mayo Clinic in Florida, the most recent clinical site to be initiated as part of an ongoing multi-center, randomized two-arm pivotal clinical trial evaluating the investigational Perimeter B-Series OCT combined...
